NECTAR LIFESCIENCES
|
The Current P/E Ratio of NECTAR LIFESCIENCES is 67.41.
Share Price | ₹32.2 | Jan 30,2025 |
Market Cap | ₹722.9 Cr | |
Earnings-TTM | ₹10.7 Cr | TTM-Consolidated Results |
Price/Earnings | 67.41x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of NECTAR LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹722.9 Cr] as on Jan 30,2025
(/) Earnings [ ₹10.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 67.41x ]
Thus, for NECTAR LIFESCIENCES , the investors are currently willing to pay 67.41 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NECTAR LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of NECTAR LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of NECTAR LIFESCIENCES
PE Ratio Performance Analysis for NECTAR LIFESCIENCES
- NECTAR LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 32.72x.
- NECTAR LIFESCIENCES 's operated at median p/e ratio of 6.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NECTAR LIFESCIENCES 's p/e ratio peaked in Mar2024 at 135.2x.
- NECTAR LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does NECTAR LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
NECTAR LIFESCIENCES | 10.73 | 67.41 | 722.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 37.60 | 418,744.0 |
CIPLA LTD | 5,000.43 | 23.55 | 117,762.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.37 | 99,705.3 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.31 | 95,929.3 |
DIVIS LABORATORIES LTD | 1,836.00 | 82.90 | 152,209.0 |
MANKIND PHARMA LTD | 2,050.73 | 50.06 | 102,663.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 61.02 | 113,621.0 |
LUPIN LTD | 2,651.94 | 35.52 | 94,191.9 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.08 | 68,671.1 |
ABBOTT INDIA LTD | 1,284.66 | 43.16 | 55,449.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NECTAR LIFESCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.37x |
Max industry PE | 82.90x |
Median industry PE | 37.60x |
Average industry PE | 41.91x |
You may also like the below Video Courses